Glenmark Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 22, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	637,520	434,866	270,463	131,124	124,718	131,124
Market Cap Growth	60.63%	60.79%	106.27%	5.14%	-4.88%	125.75%
Enterprise Value	622,857	434,470	315,126	164,781	152,778	150,427
Last Close Price	2259.10	1537.28	954.74	461.55	436.18	456.42
PE Ratio	59.86	41.53	-	44.11	13.24	13.52
Forward PE	29.22	26.02	26.45	10.10	10.59	12.50
PS Ratio	3.86	3.25	2.14	1.13	1.01	1.20
PB Ratio	6.65	4.91	3.45	1.33	1.32	1.86
P/TBV Ratio	8.20	5.89	4.15	1.86	1.83	2.77
P/FCF Ratio	-	-	-	743.80	39.15	36.78
P/OCF Ratio	-	-	-	20.97	11.25	11.59
PEG Ratio	1.31	1.25	1.12	0.63	1.71	1.14
EV/Sales Ratio	3.77	3.25	2.49	1.41	1.24	1.38
EV/EBITDA Ratio	15.09	20.04	17.22	11.53	7.99	7.74
EV/EBIT Ratio	16.13	22.78	21.80	14.48	8.30	8.77
EV/FCF Ratio	-	-	-	934.71	47.96	42.20
Debt / Equity Ratio	0.13	0.28	0.16	0.47	0.42	0.71
Debt / EBITDA Ratio	0.30	1.09	0.64	3.03	1.98	2.45
Debt / FCF Ratio	-	-	-	261.38	12.44	13.99
Net Debt / Equity Ratio	-0.15	0.09	-0.05	0.35	0.27	0.54
Net Debt / EBITDA Ratio	-0.36	0.37	-0.24	2.41	1.33	1.97
Net Debt / FCF Ratio	-	-0.50	0.37	195.11	7.99	10.77
Asset Turnover	-	0.88	0.75	0.64	0.75	0.72
Inventory Turnover	-	1.63	1.87	1.81	1.90	1.74
Quick Ratio	-	0.94	0.75	1.06	1.08	1.00
Current Ratio	-	1.56	1.28	2.10	1.77	1.75
Return on Equity (ROE)	-	12.54%	-20.70%	-0.93%	12.04%	14.77%
Return on Assets (ROA)	-	7.84%	5.36%	3.90%	7.04%	7.08%
Return on Invested Capital (ROIC)	31.57%	16.74%	-700.97%	-3.36%	11.09%	11.45%
Return on Capital Employed (ROCE)	-	18.90%	16.90%	8.00%	14.80%	15.00%
Earnings Yield	1.67%	2.41%	-5.55%	2.27%	7.55%	7.40%
FCF Yield	-	-3.63%	-4.30%	0.13%	2.55%	2.72%
Dividend Yield	0.22%	0.16%	0.26%	0.54%	0.57%	0.55%
Payout Ratio	13.25%	6.73%	-	23.68%	9.84%	7.26%
Buyback Yield / Dilution	-0.04%	-0.01%	-0.00%	-	-	-
Total Shareholder Return	0.18%	0.15%	0.26%	0.54%	0.57%	0.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.